ArticleHuman vaccines & immunotherapeutics2022
Key stakeholder perspectives on challenges and opportunities for rural HPV vaccination in North and South Carolina.
Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Boot Camp Translation using Community-Engaged messaging for adolescent Vaccination: A Cluster-Randomized trial.Vaccine · 2024Trial
- Implementing School-Associated Vaccination Events in Colorado Public Schools: A Statewide Survey of Nurses.The Journal of school health · 2026Article
- An Analysis of Multilevel Barriers to Human Papillomavirus Vaccination Uptake Among Rural U.S. Adolescents.Vaccines · 2026Review
- Review
- Applicability of the levels of the socio-ecological model in the context of cervical cancer prevention: a scoping review.Cancer causes & control : CCC · 2026Article
- Context-specific strategies for enhancing HPV vaccination: key informant perspectives from selected U.S. jurisdictions in the post-COVID-19 era.Frontiers in public health · 2026Article
- Young adult perspectives on deciding to get human papillomavirus (HPV) vaccination in urban and rural communities: A qualitative research study.Human vaccines & immunotherapeutics · 2025Article
- Messaging Preferences about the COVID-19 Vaccine among Adults in Eastern North Carolina.Journal of community health · 2025Article
- Demographic, clinical, and social characteristics of anal cancer among patients stratified by age (<50 and ≥50 years) in Alabama between 2012 and 2018.Cancer epidemiology · 2024Article
- Demographic Influences on Adult HPV Vaccination: Results from a Cross-Sectional Survey in Tennessee.Healthcare (Basel, Switzerland) · 2024Article
- Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia.BMC cancer · 2024Article
- Assessing Barriers to Human Papillomavirus (HPV) Vaccination in At-Risk Rural Communities of Western North Carolina, United States.Vaccines · 2023Article
- Lessons Learned from All for Them: Best Practices for a Cross-Collaboration Approach to HPV Vaccination in Public Schools.Vaccines · 2023Article
- Perceived Barriers and Use of Evidence-Based Practices for Adolescent HPV Vaccination among East Texas Providers.Vaccines · 2023Article
- Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach.Human vaccines & immunotherapeutics · 2022Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
Abstract
The objective of this study was to identify factors at the individual, provider, and systems levels that serve as challenges or opportunities for increasing adolescent vaccination-including Human Papillomavirus (HPV) vaccination-in rural communities in the southern United States (US). As part of a broader study to increase HPV vaccine uptake in the southern US, we conducted in-depth interviews with vaccination stakeholders representing public health and education agencies in North Carolina (NC) and South Carolina (SC). Fourteen key stakeholders were recruited using purposive sampling to obtain insights into challenges and solutions to rural-urban disparities in HPV vaccination coverage. Stakeholders were also queried about their experiences and attitudes toward school-based vaccination promotion programs and campaigns. We used a rapid qualitative approach to analyze the data. Stakeholders identified factors at the individual, provider, and systems levels that serve as challenges to vaccination in rural communities. Similar to previous studies, stakeholders mentioned challenges with healthcare access and vaccine-related misconceptions that pose barriers to HPV vaccination for rural residents. Systems-level challenges identified included limited access to high-speed internet in rural areas that may impact providers' ability to interface with state-level digital systems such as the vaccination registry. Stakeholders identified a number of opportunities to increase HPV vaccination coverage, including through school-based health promotion programs. Stakeholders strongly supported school-based programs and approaches to strengthen confidence and demand for HPV vaccination and to help address persistent social determinants and system level factors that pose challenges to HPV vaccination coverage in many rural areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.